Kemper M A, Stout C D, Lloyd S J, Prasad G S, Fawcett S E, Armstrong F A, Shen B, Burgess B K
Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92697-3900, USA.
J Biol Chem. 1997 Jun 20;272(25):15620-7. doi: 10.1074/jbc.272.25.15620.
Ferredoxins that contain [4Fe-4S]2+/+ clusters often obtain three of their four cysteine ligands from a highly conserved CysXXCysXXCys sequence motif. Little is known about the in vivo assembly of these clusters and the role that this sequence motif plays in that process. In this study, we have used structure as a guide in attempts to direct the formation of a [4Fe-4S]2+/+ in the [3Fe-4S]+/0 location of native (7Fe) Azotobacter vinelandii ferredoxin I (AvFdI) by providing the correct three-dimensional orientation of cysteine ligands without introducing a CysXXCysXXCys motif. Tyr13 of AvFdI occupies the position of the fourth ligating cysteine in the homologous and structurally characterized 8Fe ferredoxin from Peptococcus aerogenes and a Y13C variant of AvFdI could be easily modeled as an 8Fe protein. However, characterization of purified Y13C FdI by UV-visible spectra, circular dichroism, electron paramagnetic resonance spectroscopies, and by x-ray crystallography revealed that the protein failed to use the introduced cysteine as a ligand and retained its [3Fe-4S]+/0 cluster. Further, electrochemical characterization showed that the redox potential and pH behavior of the cluster were unaffected by the substitution of Tyr by Cys. Although Y13C FdI is functional in vivo it does differ significantly from native FdI in that it is extremely unstable in the reduced state possibly due to increased solvent exposure of the [3Fe-4S]0 cluster. Surprisingly, the x-ray structure showed that the introduced cysteine was modified to become a persulfide. This modification may have occurred in vivo via the action of NifS, which is known to be expressed under the growth conditions used. It is interesting to note that neither of the two free cysteines present in FdI was modified. Thus, if NifS is involved in modifying the introduced cysteine there must be specificity to the reaction.
含有[4Fe-4S]2+/+簇的铁氧化还原蛋白通常从高度保守的CysXXCysXXCys序列基序中获得其四个半胱氨酸配体中的三个。关于这些簇的体内组装以及该序列基序在这一过程中所起的作用,人们了解甚少。在本研究中,我们以结构为指导,试图通过提供半胱氨酸配体的正确三维取向,而不引入CysXXCysXXCys基序,来引导在天然(7Fe)棕色固氮菌铁氧化还原蛋白I(AvFdI)的[3Fe-4S]+/0位置形成[4Fe-4S]2+/+。AvFdI的Tyr13在来自产气消化球菌的同源且结构已表征的8Fe铁氧化还原蛋白中占据第四个连接半胱氨酸的位置,并且AvFdI的Y13C变体可以很容易地被模拟为8Fe蛋白。然而,通过紫外可见光谱、圆二色性、电子顺磁共振光谱以及X射线晶体学对纯化的Y13C FdI进行表征发现,该蛋白未能将引入的半胱氨酸用作配体,并保留了其[3Fe-4S]+/0簇。此外,电化学表征表明,该簇的氧化还原电位和pH行为不受半胱氨酸取代酪氨酸的影响。尽管Y13C FdI在体内具有功能,但它与天然FdI确实有显著差异,因为它在还原状态下极其不稳定,这可能是由于[3Fe-4S]0簇的溶剂暴露增加所致。令人惊讶的是,X射线结构表明引入的半胱氨酸被修饰成了过硫化物。这种修饰可能是在体内通过NifS的作用发生的,已知NifS在所用的生长条件下会表达。有趣的是,FdI中存在的两个游离半胱氨酸均未被修饰。因此,如果NifS参与修饰引入的半胱氨酸,那么该反应必定具有特异性。